Matthew Ros - Net Worth and Insider Trading

Matthew Ros Net Worth

The estimated net worth of Matthew Ros is at least $122,286 dollars as of 2024-11-10. Matthew Ros is the See Remarks of Epizyme Inc and owns about 83,188 shares of Epizyme Inc (EPZM) stock worth over $122,286. Details can be seen in Matthew Ros's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Matthew Ros has not made any transactions after 2021-02-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Matthew Ros

To

Matthew Ros Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Matthew Ros owns 2 companies in total, including Cogent Biosciences Inc (COGT) , and Epizyme Inc (EPZM) .

Click here to see the complete history of Matthew Ros’s form 4 insider trades.

Insider Ownership Summary of Matthew Ros

Ticker Comapny Transaction Date Type of Owner
COGT Cogent Biosciences Inc 2021-01-04 director
EPZM Epizyme Inc 2021-02-04 Chief Operating Officer

Matthew Ros Latest Holdings Summary

Matthew Ros currently owns a total of 1 stock. Matthew Ros owns 83,188 shares of Epizyme Inc (EPZM) as of February 4, 2021, with a value of $122,286.

Latest Holdings of Matthew Ros

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
EPZM Epizyme Inc 2021-02-04 83,188 1.47 122,286

Holding Weightings of Matthew Ros


Matthew Ros Form 4 Trading Tracker

According to the SEC Form 4 filings, Matthew Ros has made a total of 6 transactions in Epizyme Inc (EPZM) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Epizyme Inc is the sale of 894 shares on February 4, 2021, which brought Matthew Ros around $10,022.

Insider Trading History of Matthew Ros

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Matthew Ros Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Matthew Ros Ownership Network

Ownership Network List of Matthew Ros

No Data

Ownership Network Relation of Matthew Ros

Insider Network Chart

Matthew Ros Owned Company Details

What does Cogent Biosciences Inc do?

Who are the key executives at Cogent Biosciences Inc?

Matthew Ros is the director of Cogent Biosciences Inc. Other key executives at Cogent Biosciences Inc include 10 percent owner & other: See Remarks Fairmount Funds Management Llc , Chief Legal Officer Evan Kearns , and Chief Financial Officer John L. Green .

Cogent Biosciences Inc (COGT) Insider Trades Summary

Over the past 18 months, Matthew Ros made no insider transaction in Cogent Biosciences Inc (COGT). Other recent insider transactions involving Cogent Biosciences Inc (COGT) include a net purchase of 800,000 shares made by Fairmount Funds Management Llc ,

In summary, during the past 3 months, insiders sold 0 shares of Cogent Biosciences Inc (COGT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cogent Biosciences Inc (COGT) were sold and 800,000 shares were bought by its insiders, resulting in a net purchase of 800,000 shares.

Cogent Biosciences Inc (COGT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Cogent Biosciences Inc Insider Transactions

No Available Data

Matthew Ros Mailing Address

Above is the net worth, insider trading, and ownership report for Matthew Ros. You might contact Matthew Ros via mailing address: C/o Epizyme, Inc., 400 Technology Square, Cambridge Ma 02139.